Mindus P, Rasmussen S A, Lindquist C
Department of Psychiatry and Psychology, Karolinska Institute, Stockholm, Sweden.
J Neuropsychiatry Clin Neurosci. 1994 Fall;6(4):467-77. doi: 10.1176/jnp.6.4.467.
A minority of patients with obsessive-compulsive disorder (OCD) have a chronic course and extreme disability, with symptoms refractory to pharmacological and psychological treatment. Considerable uncontrolled evidence suggests such cases may respond to neurosurgical intervention. The authors update current stereotactic procedures and their efficacy, safety, and side effect profiles. The design of an ongoing placebo-controlled trial of Gamma Knife capsulotomy for refractory OCD is outlined. Drug treatment of OCD may be assumed to affect a proposed functional imbalance between the frontal lobes and other parts of the brain. As for neurosurgical treatments, both the effects and side effects may be viewed as expressions of their influence on this functional imbalance.
少数强迫症(OCD)患者病程呈慢性且极度残疾,症状对药物和心理治疗均无反应。大量未经对照的证据表明,此类病例可能对神经外科干预有反应。作者更新了当前的立体定向手术及其疗效、安全性和副作用情况。概述了一项正在进行的关于伽玛刀内囊切开术治疗难治性强迫症的安慰剂对照试验的设计。强迫症的药物治疗可能被认为会影响大脑额叶与其他部分之间假定的功能失衡。至于神经外科治疗,其效果和副作用都可被视为对这种功能失衡影响的表现。